首页 | 本学科首页   官方微博 | 高级检索  
     

48例冠心病患者血脂测定临床分析
引用本文:谭显清,李骏. 48例冠心病患者血脂测定临床分析[J]. 检验医学与临床, 2010, 7(11): 1040-1041
作者姓名:谭显清  李骏
作者单位:四川省达州市通川区中医院检验科,635000
摘    要:目的调查冠心病(CHD)患者血脂代谢状况,探讨血脂变化在触发CHD发生发展中的作用及临床意义。方法用日立7020全自动生化分析仪检测48例CHD患者和50例健康对照者血清总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和脂蛋白(a)[Lp(a)]水平。TC、TG测定采用氧化酶法,HDL-C、LDL-C测定采用直接法,Lp(a)测定采用胶乳增强免疫比浊法。结果 CHD患者TC(5.28±1.07)mmol/L、TG(1.83±0.60)mmol/L、LDL-C(3.41±1.29)mmol/L、Lp(a)(269±170)mg/L,明显比对照组[(4.25±0.93)mmol/L、(1.30±0.43)mmol/L、(2.51±0.87)mmol/L、(138±96)mg/L]高,差异有统计学意义(P0.001);而CHD患者HDL-C[(1.15±0.34)mmol/L]却比对照组[(1.32±0.43)mmol/L]低,差异也有统计学意义(P0.05)。结论 CHD患者存在不同程度的血脂代谢紊乱,TC、TG、LDL-C升高和HDL-C降低将触发CHD的发生和发展。

关 键 词:冠心病  血脂  预测  风险指标

Clinical analysis of determination of serumlipid in 48 cases of coronary heart disease
TAN Xian-qing,LI Jun. Clinical analysis of determination of serumlipid in 48 cases of coronary heart disease[J]. Laboratory Medicine and Clinic, 2010, 7(11): 1040-1041
Authors:TAN Xian-qing  LI Jun
Affiliation:.Department of Clinical Laboratory,Traditional Chinese Medicine Hospital of Tongchuan District of Dazhou City,Dazhou,Sichuan 635000,China
Abstract:Objective To investigate the condition of lipids metabolism in the patients with coronary heart disease (CHD) and to study the clinical significance and role of changes of serum lipids on triggering occurrence and development of CHD.Methods The levels of total cholesterol (TC),triglyceride (TG),high density lipoprotein cholesterol (HDL-C),low density lipoprotein cholesterol (LDL-C) and lipoprotein a [Lp(a)] were measured with HITACHI 7020 automatic biochemistry analyzer in 48 patients with CHD and in 50 healthy subjects,respectively.TC and TG were detected by enzymatic oxidation.HDL-C,LDL-C were measured by the direct method.Lp(a) was measured by latex enhanced immunoturbidimetric assay.Results CHD patients had significantly higher levels of TC,TG,LDL-C and Lp(a) (5.28±1.07)mmol/L,(1.83±0.60)mmol/L,(3.41±1.29)mmol/L and (269±170)mg/L,respectively) compared to those in controls (4.25±0.93)mmol/L,(1.30±0.43)mmol/L,(2.51±0.87)mmol/L,(138±96)mg/L (P0.001).However,the concentration of HDL-C of CHD group was obviously lower than that of controls [(1.15±0.34)mmol/L vs (1.32±0.43)mmol/L,P0.05].Conclusion There is a metabolic disorder of serum lipids in the patients with CHD.It will result in occurrence and development of CHD which elevates levels of TC,TG,LDL-C and Lp(a) and lowers concentration of HDL-C.
Keywords:coronary heart disease  serum lipids  prediction  markers of risk
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号